Janumet costs between $335 and $523 for a 60-tablet supply in the United States, depending on the pharmacy and whether you use a discount coupon. That price tag comes down to one core factor: until very recently, Merck held exclusive patents on sitagliptin, the active ingredient that makes Janumet more than just metformin. Without generic competition, Merck set the price, and the U.S. pharmaceutical market had no mechanism to push it lower.
Patent Protection Kept Generics Off the Market
Janumet combines two diabetes drugs into one pill: sitagliptin and metformin. Metformin has been generic for decades and costs pennies per tablet. Sitagliptin is the expensive half. Merck’s patents on sitagliptin kept every other manufacturer from producing competing versions, and those patents didn’t begin expiring until late 2025. The final qualifying patent for both Janumet and Janumet XR runs through November 24, 2026.
This patent exclusivity is the single biggest reason for the price. When one company controls the entire supply of a medication, there’s no competitive pressure to lower costs. Merck could price Janumet at roughly $5 per tablet because no alternative existed for patients who needed sitagliptin specifically. Metformin alone wouldn’t do the same job, and switching to a different drug class isn’t always an option.
Generics Are Finally Arriving
The FDA approved the first generic version of Janumet (made by Sandoz) on December 2, 2025. A generic of Janumet XR from PH Health Limited followed on June 4, 2025. A standalone generic of sitagliptin (the Januvia component) was also approved in late December 2025. These approvals mark a turning point, though it can take months after FDA approval for generics to actually appear on pharmacy shelves and begin driving prices down in practice.
Early generic pricing already shows a difference. A 60-tablet supply of generic sitagliptin/metformin lists at around $246, compared to roughly $330 or more for branded Janumet. That gap will likely widen as more manufacturers enter the market. Historically, generic drug prices drop significantly once three or four competitors are selling the same product.
U.S. Prices Dwarf International Costs
The price disparity between the U.S. and the rest of the world is staggering. American pharmacies charge an average of about $4.84 per tablet for Janumet. International pharmacies verified by PharmacyChecker sell the same medication for as little as $0.33 per tablet, a 93% difference. Countries with government-negotiated drug pricing or national formularies pay a fraction of what American patients face.
This gap exists because the U.S. is one of the few countries where pharmaceutical companies can set their own prices without government price controls. Medicare was historically prohibited from negotiating drug prices directly with manufacturers, and private insurers negotiate individually with varying results. The Inflation Reduction Act has begun changing this for some Medicare drugs, but Janumet’s pricing has largely reflected the old system.
Why a Combination Pill Costs More
You might wonder why you can’t just take cheap generic metformin and buy sitagliptin separately. You can, but sitagliptin alone (branded as Januvia) carries a similarly high price because it’s the patented component. The combination pill adds manufacturing complexity on top of that. Janumet XR uses extended-release technology that controls how the metformin portion dissolves over time, which adds formulation costs. Even the first approved generic XR version uses a different form of sitagliptin (the free base rather than the phosphate salt) and different inactive ingredients, reflecting how these formulations aren’t simple to replicate.
Still, the formulation cost is a tiny fraction of the retail price. The real cost driver remains market exclusivity, not manufacturing.
Ways to Lower Your Out-of-Pocket Cost
If you’re paying for branded Janumet right now, several options can reduce the bill substantially.
- Merck’s savings card: Privately insured patients can pay as little as $5 per prescription, with Merck covering up to $150 off your out-of-pocket cost on each fill (up to a 90-day supply). You’re responsible for the first $5.
- Merck Patient Assistance Program: If you’re uninsured or your insurance doesn’t cover Janumet, Merck provides the medication free to eligible individuals. The program doesn’t publish specific income cutoffs publicly, but you can apply through Merck’s patient support portal.
- Discount coupons: Services like GoodRx can bring a 60-tablet supply down to around $336, compared to retail prices above $500.
- Generic substitution: Ask your pharmacist whether a generic sitagliptin/metformin product is available at your pharmacy. As generics roll out through 2025 and 2026, this will become the most straightforward way to cut costs.
The pricing landscape for Janumet is shifting faster now than at any point in the drug’s history. With multiple generics approved and more manufacturers likely entering the market before the final patent expires in late 2026, prices should continue falling. For patients who have been paying hundreds of dollars a month, the next year or two should bring meaningful relief.